Natera

205.88
Open
202.60
Market Cap
28.93B+
High
207.45
Low
201.94
Close
NaN
Volume
239.33K+
P/E Ratio
-134.05
Div/Yield
0.00%

About Natera

Natera Inc 是一家專注於診斷和研究的公司,擁有獨特的分子和生物信息學技術。該公司的主要產品包括:全景無創產前檢測 (NIPT),這是一種通過從母體抽血來篩查胎兒及雙胞胎的染色體異常的檢測方法;Horizon攜帶者篩查 (HCS),用於確定攜帶者是否可能將多種嚴重遺傳疾病遺傳給其子女;Signatera 分子殘留病 (MRD) 檢測,能夠檢測先前被診斷為癌症的患者體內的循環腫瘤 DNA,以評估分子殘留病的情況並監測復發;以及 Prospera,這是一種用於評估器官移植後的排斥反應的檢測工具。

如何購買 Natera (NTRA)

登入
1分鐘開戶

1分鐘開戶

僅需1分鐘即可完成帳戶申請和驗證。整個過程完全自助,支援 RockFlow App 和網頁端操作。

充值資金

充值資金

帳戶驗證完成後,您可以使用首選的支付方式向帳戶充值。

購買 NTRA

購買 NTRA

透過 RockFlow App 或網頁端搜尋 NTRA,輸入您想要投資的金額,然後點擊確認即可完成交易。

logo

Social

Download

google playapp store

© Rockalpha Limited. All Rights Reserved.

Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider. Rockalpha Limited is not licensed by a New Zealand regulator to provide the client money or property services, and Rockalpha Limited’s registration on the New Zealand register of financial service providers or membership of the Insurance & Financial Services Ombudsman Scheme does not mean that Rockalpha Limited is subject to active regulation or oversight by a New Zealand regulator.Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider.